The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities

Prenatal Diagnosis

Volumn 28, Issue 6, 2008, Pages 508-511

  Lo, T K ^a   Lau, W L ^a   Lai, F K ^a   Lam, H ^a   Tse, H Y ^a   Leung, W C ^a   Chin, R K H ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

Foetal abnormality; Gestational age; Second trimester; Termination of pregnancy

Indexed keywords

ERGOMETRINE PLUS OXYTOCIN; METOCLOPRAMIDE; MISOPROSTOL; OXYTOCIN; PETHIDINE;

ABORTION; ADULT; ANALGESIA; ARTICLE; BODY MASS; DIARRHEA; FEMALE; FETUS; FETUS DISEASE; FEVER; GESTATIONAL AGE; HUMAN; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADULT; CONGENITAL ABNORMALITIES; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 46749123592     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2012     Document Type: Article

References (11)

1. Dickinson JE, Evans SF. 2002. The optimisation of intra-vaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 186: 470-474.
2. Dickinson JE, Evans SF. 2003. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol 101: 1294-1299.
3. Dickinson JE, Godfrey ME, Evans SF. 1998. Efficacy of intra-vaginal misoprostol in second-trimester pregnancy termination: a randomised controlled trial. J Matern Fetal Med 7: 115-119.
4. Dodd J, O'Brien L, Coffey J. 2005. Misoprostol for second and third trimester termination of pregnancy: a review of practice at the Women's and Children's Hospital, Adelaide, Australia. Aust N Z J Obstet Gynaecol 45: 25-29.
5. Goldberg AB, Greenberg MB, Darncy PD. 2001. Misoprostol and pregnancy. N Engl J Med 344: 38-47.
6. Hinshaw K, El-Refaey H, Rispin R, Templeton A. 1995. Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol. BJOG 102: 559-560.
7. Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. 2007. Mid-trimester induced abortion: a review. Hum Reprod Update 13(1): 37-52.
8. Tang OS, Gemzell-Danielsson K, Ho PC. 2007. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynecol Obstet 99: S160-S167.
9. Wong KS, Ngai CS, Wong AY, Tang LC, Ho PC. 1998. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomised trial. Contraception 59: 207-210.
10. Wong KS, Ngai CS, Yeo EL, Tang LC, Ho PC. 2000. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomised comparative trial. Hum Reprod 15: 709-712.
11. Wyldes MP, Tonks AM. 2007. Termination of pregnancy for fetal anomaly: a population-based study 1995 to 2004. BJOG 114: 639-642.